N affected | Median months | % survival | |
---|---|---|---|
Overall survival | |||
5-year OS | 25 | 36 | 77% |
10-year OS | 29 | 41 | 74% |
Disease-specific survival | |||
5-year DSS | 17 | 41 | 85% |
10-year DSS | 21 | 47 | 81% |
Disease-free survival | |||
5-year DFS | 36 | 20 | 67% |
10-year DFS | 49 | 31 | 55% |
Locoregional recurrence-free survival | |||
5-year RFS | 19 | 27 | 83% |
10-year RFS | 26 | 36 | 76% |
Metastatic-free survival | |||
5-year MFS | 26 | 22 | 76% |
10-year MFS | 33 | 28 | 70% |